| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |